Guangzhou Innogen Updates Corporate Articles Following H Share Listing

Guangzhou Innogen Pharmaceutical Group Co Ltd Class H ( (HK:2591) ) has issued an announcement.

Guangzhou Innogen Pharmaceutical Group Co., Ltd has announced amendments to its Articles of Association following its issuance and listing of H shares on the Main Board of the Hong Kong Stock Exchange. These updates encompass changes to registered capital, the total number of shares, and the business scope to align with regulatory advice and actual business conditions, reflecting the company’s evolving operational scale and market positioning. The amendments are expected to strengthen corporate governance and ensure compliance with domestic and international regulatory standards, signaling the company’s growth and commitment to its stakeholders.

More about Guangzhou Innogen Pharmaceutical Group Co Ltd Class H

Guangzhou Innogen Pharmaceutical Group Co., Ltd is a pharmaceutical company based in China that focuses on research and development (R&D), manufacturing, and sales of pharmaceutical products, along with contract manufacturing. The company is also involved in technical services, medical research, and the production of medical devices across multiple classes, as well as import-export and pharmaceutical Internet information services.

Average Trading Volume: 687,288

For detailed information about 2591 stock, go to TipRanks’ Stock Analysis page.